regwall-pro
China’s ‘Silicon Valley’ is building robots and fortune-telling AI apps at the same time
HANGZHOU, China — In what is sometimes dubbed China’s Silicon Valley, tech giants and startups in Hangzhou are racing to build cutting-edge chips, robotics and brain-computer interfaces. Across town, aspiring founders are creating AI pets and fortune-telling apps. The city on China’s southeastern coast is reinventing itself as an artificial intelligence hub. A year after the […]
Read More
Warren Buffett’s exit leaves open question: Who runs Berkshire’s $300 billion equity portfolio?
As Berkshire Hathaway marks Warren Buffett ‘s official retirement Wednesday, attention is shifting to a less settled part of the succession plan: the fate of its $300 billion equity portfolio. For decades, Berkshire’s stock holdings have reflected Buffett’s long-term investing judgment and his willingness to deploy capital aggressively during market turmoil. With no obvious successor […]
Read More
Europe’s banks have had a stellar year. Now they face one big question in 2026
Key Points Europe’s banking sector has flourished in 2025, with lenders notching their strongest annual showing since 1997. Now, after a strong third-quarter earnings season, banks must decide how and where to put their “significant” excess capital to work in 2026. Strategists see the sector as a strong diversification play for investors in 2026. Source
Read More
Global stock markets’ winners and losers of 2025 — and where they’re headed
Global stocks have seen a stellar run in 2025, yet widening performance gaps and rising expectations suggest the new year may separate durable winners from fleeting momentum trades. The MSCI All Country World Index , which measures the performance of over 2,500 large and mid-cap equities from developed and emerging markets, has climbed over 21% […]
Read More
Emerging markets had a bumper year — here’s what could be in store in 2026
Emerging markets are poised to end 2025 on a high, as a flurry of positive momentum propelled their stock indexes to record highs that many expect will be extended even further in the new year. The MSCI Emerging Markets Index — comprised of large- and mid-cap stocks listed across emerging markets countries — has surged […]
Read More
UK stocks outperformed Wall Street this year — and investors see more upside ahead in 2026
An AI bull run has driven stocks to new highs in America this year. But the country’s major indexes have been outperformed by U.K. stocks in 2025 so far. Political and economic uncertainty hasn’t stopped London’s benchmark FTSE 100 index from gaining more than 21.1% so far this year, ahead of the tech-heavy Nasdaq Composite […]
Read More
Check out the winning hedge fund strategies of 2025
Healthcare stocks, media and telecoms companies, and Asian equities were among hedge funds’ best trades this year, with just two weeks left on the calendar. Overall, equity-focused funds — which trade stocks long and short by sector, geography or theme — are the top-performing category in the 11 months to the end of November, according […]
Read More
The next rare earths crunch? Top mining CEO warns copper supply challenges aren’t going anywhere
Copper supply constraints have led to soaring prices and stockpiling in 2025 – and according to the CEO of one of the world’s largest mining firms, elevated prices aren’t likely to climb down anytime soon. Copper prices hit a record high of $11,952 per metric ton on Friday, the latest record high this year driven […]
Read More
From Starbucks to Burger King: Western food giants are selling large stakes to Chinese private equity funds
Starbucks and Burger King are betting big on a partnership model that’s gaining traction in China: selling majority stakes to local private equity firms as the battle for market share rages on. Foreign food-and-beverage chains once thrived in China without adapting much — premium Western products practically sold themselves. Today, decisions made from distant headquarters […]
Read More
Europe’s best-performing stock is up 1,400% this year. Here’s what’s next
Key Points Abivax shares are up more than 1,400% year to date as investors are optimistic about the prospects of its treatment for ulcerative colitis. “We are certainly excited about the work we are doing, and we’ve been greeted again by the medical community as becoming possibly this next standard of care in ulcerative colitis,” […]
Read More